NextGen Healthcare NXGN
$ 23.94
0.0%
Quarterly report 2023-Q3
added 10-24-2023
NextGen Healthcare Balance Sheet 2011-2024 | NXGN
Annual Balance Sheet NextGen Healthcare
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-42.1 M | 40.4 M | -22.1 M | 8.16 M | -21.6 M | 87.1 M | -119 M | -103 M | -106 M | -134 M | -117 M |
Long Term Debt |
18.5 M | 129 M | 11 M | 37 M | 15 M | 105 M | - | - | - | - | - |
Long Term Debt Current |
12.7 M | 10.6 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 176 M | 28.7 M | 57.8 M | 39.5 M | 123 M | 21.9 M | 26.1 M | 8.98 M | 15.7 M | 17.4 M |
Total Current Liabilities |
181 M | 143 M | 128 M | 135 M | 129 M | 138 M | 155 M | 124 M | 127 M | 129 M | 137 M |
Total Liabilities |
213 M | 320 M | 157 M | 192 M | 168 M | 261 M | 177 M | 150 M | 136 M | 145 M | 154 M |
Deferred Revenue |
52.9 M | 61 M | 60 M | 58.4 M | 56.5 M | 62.1 M | 71.1 M | 71.2 M | 65.5 M | 83.1 M | 76.7 M |
Retained Earnings |
129 M | 119 M | 112 M | 78.7 M | 76.2 M | 58 M | 84.5 M | 99.9 M | 127 M | 126 M | 91.1 M |
Total Assets |
644 M | 720 M | 533 M | 516 M | 473 M | 531 M | 461 M | 445 M | 443 M | 440 M | 379 M |
Cash and Cash Equivalents |
73.3 M | 138 M | 33.1 M | 28.8 M | 37.7 M | 27.2 M | 119 M | 103 M | 106 M | 134 M | 117 M |
Book Value |
432 M | 400 M | 376 M | 323 M | 305 M | 269 M | 284 M | 295 M | 307 M | 295 M | 225 M |
Total Shareholders Equity |
432 M | 400 M | 376 M | 323 M | 305 M | 269 M | 284 M | 295 M | 307 M | 295 M | 225 M |
All numbers in USD currency
Quarterly Balance Sheet NextGen Healthcare
2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
268 M | 267 M | - | 5.15 M | - | 11.9 M | 12.8 M | 14.6 M | 16.4 M | 18.5 M | 29.3 M | 36.4 M | 36.1 M | 38.8 M | 39.3 M | 41.6 M | 44.3 M | - | - | - | - | - | - | - | - | - | - | - | - | 105 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
434 M | 496 M | - | 185 M | - | 205 M | 194 M | 200 M | 186 M | 213 M | 230 M | 253 M | 366 M | 320 M | 223 M | 182 M | 186 M | 157 M | 165 M | 180 M | 198 M | 192 M | 171 M | 189 M | 176 M | 168 M | 165 M | 193 M | 235 M | 261 M | 149 M | 149 M | 161 M | 177 M | 157 M | 155 M | 151 M | 156 M | 148 M | 147 M | 135 M | 136 M | 119 M | 144 M | 154 M | 145 M | 159 M | 148 M | 150 M | 154 M |
Deferred Revenue |
45.9 M | 61.6 M | - | 62.5 M | - | 61.3 M | 54.9 M | 53.5 M | 52.3 M | 52.9 M | 48.7 M | 48.4 M | 51.2 M | 56.8 M | 52.9 M | 54.1 M | 54 M | 56 M | 50.4 M | 50 M | 52.2 M | 54.1 M | 52.8 M | 52.3 M | 51.5 M | 52.4 M | 49.8 M | 52.3 M | 54.4 M | 57.9 M | 55.1 M | 57.7 M | 61.9 M | 66.3 M | 67.8 M | 69.6 M | 70.7 M | 71.1 M | 72.7 M | 66.6 M | 62.7 M | 65.2 M | 63 M | 68 M | 70.7 M | 83.1 M | 90.6 M | 83.3 M | 80 M | 76.7 M |
Retained Earnings |
139 M | 128 M | - | 145 M | - | 130 M | 130 M | 125 M | 131 M | 129 M | 129 M | 129 M | 118 M | 119 M | 123 M | 119 M | 113 M | 112 M | 108 M | 103 M | 89.8 M | 78.7 M | 89.8 M | 88.2 M | 80.2 M | 76.2 M | 71.8 M | 61.3 M | 57.3 M | 58 M | 74.3 M | 77.7 M | 80.1 M | 84.5 M | 84.4 M | 88.5 M | 94.4 M | 99.9 M | 105 M | 129 M | 129 M | 127 M | 141 M | 136 M | 131 M | 126 M | 121 M | 110 M | 99.9 M | 91.1 M |
Total Assets |
858 M | 896 M | - | 627 M | - | 628 M | 605 M | 636 M | 625 M | 644 M | 656 M | 672 M | 770 M | 720 M | 623 M | 573 M | 567 M | 533 M | 531 M | 536 M | 535 M | 516 M | 501 M | 514 M | 490 M | 473 M | 463 M | 479 M | 505 M | 531 M | 433 M | 436 M | 441 M | 461 M | 439 M | 440 M | 442 M | 451 M | 448 M | 467 M | 445 M | 443 M | 440 M | 457 M | 460 M | 440 M | 442 M | 417 M | 400 M | 379 M |
Cash and Cash Equivalents |
53.9 M | 98.7 M | - | 78.3 M | - | 59.8 M | 49.4 M | 81.6 M | 63 M | 73.3 M | 89.5 M | 103 M | 192 M | 138 M | 26.8 M | 42.9 M | 28.6 M | 33.1 M | 30.1 M | 32.4 M | 26.5 M | 28.8 M | 23.4 M | 26.6 M | 23.3 M | 37.7 M | 24 M | 26.2 M | 26.3 M | 27.2 M | 92.6 M | 98.6 M | 92.6 M | 105 M | 114 M | 115 M | 108 M | 103 M | 82.1 M | 72.8 M | 118 M | 106 M | 102 M | 117 M | 130 M | 106 M | 129 M | 126 M | 124 M | 134 M |
Book Value |
423 M | 400 M | - | 442 M | - | 423 M | 411 M | 435 M | 439 M | 432 M | 426 M | 420 M | 404 M | 400 M | 400 M | 391 M | 381 M | 376 M | 365 M | 355 M | 337 M | 323 M | 331 M | 326 M | 314 M | 305 M | 298 M | 285 M | 270 M | 269 M | 285 M | 287 M | 280 M | 284 M | 283 M | 285 M | 291 M | 295 M | 300 M | 321 M | 310 M | 307 M | 321 M | 312 M | 307 M | 295 M | 282 M | 269 M | 251 M | 225 M |
Total Shareholders Equity |
423 M | 400 M | - | 442 M | 429 M | 423 M | 411 M | 435 M | 439 M | 439 M | 426 M | 426 M | 420 M | 400 M | 400 M | 400 M | 391 M | 381 M | 365 M | 365 M | 355 M | 323 M | 331 M | 326 M | 314 M | 305 M | 298 M | 285 M | 270 M | 269 M | 285 M | 287 M | 280 M | 284 M | 283 M | 285 M | 291 M | 295 M | 300 M | 321 M | 310 M | 307 M | 321 M | 312 M | 307 M | 295 M | 282 M | 269 M | 251 M | 225 M |
All numbers in USD currency